Virax Biolabs Group Ltd - SHS NEW (VRAX)

Historical Holders from Q4 2023 to Q4 2024

Symbol
VRAX on Nasdaq
CUSIP
G9495L125
Type / Class
Equity / SHS NEW
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
63K
Holdings value
$141K
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
7
Number of buys
6
Number of sells
-4
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of Virax Biolabs Group Ltd - SHS NEW (VRAX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q4 63K $141K -$295K $2.25 7
2024 Q3 218K $424K +$329K $1.94 5
2024 Q2 70.8K $81.8K +$68.1K $1.16 7
2024 Q1 17.5K $12.5K -$182K $0.72 3
2023 Q4 134K $195K +$195K $1.46 4